US FDA Approves ZYNTEGLO® (betibeglogene autotemcel)

  • 1 Replies
  • 136 Views
*

Offline Bostonian_04

  • ****
  • 395
  • Gender: Male
US FDA Approves ZYNTEGLO® (betibeglogene autotemcel)
« on: August 18, 2022, 02:14:15 PM »
FINALLY!

Bluebird bio announced that the U.S. Food and Drug Administration (FDA) has approved ZYNTEGLO® (betibeglogene autotemcel), a one-time gene therapy to treat patients with beta-thalassemia who require regular red blood cell (RBC) transfusions.

You can find a full press release and more information at https://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-announces-fda-approval-zynteglor-first-gene-therapy
Quis custodiet ipsos custodes ? - Plato

*

Offline Andy Battaglia

  • *****
  • 8764
  • Gender: Male
  • Will thal rule you or will you rule thal?
Re: US FDA Approves ZYNTEGLO® (betibeglogene autotemcel)
« Reply #1 on: September 03, 2022, 08:10:39 PM »
The price tag is enormous. Do you know anything about if insurance companies will help cover the cost?
Andy

All we are saying is give thals a chance.

 

SMF spam blocked by CleanTalk